Impact of Nutritional Supplementation on Aerobic Performance and Fatigue
1 other identifier
interventional
30
1 country
1
Brief Summary
Compare an over-the-counter dietary supplement (NutraStem Active®) and placebo over a 30-day intervention on aerobic exercise performance and fatigue. The hypothesis is that supplementation with NutraStem Active® improve aerobic performance and reduce subjective measures of fatigue.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 11, 2014
CompletedStudy Start
First participant enrolled
May 1, 2014
CompletedFirst Posted
Study publicly available on registry
May 9, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2015
CompletedResults Posted
Study results publicly available
December 7, 2020
CompletedDecember 7, 2020
December 1, 2015
1 year
April 11, 2014
July 16, 2019
November 12, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Perceived Exertion
Ratings of perceived exertion (RPE) as measured on a self-report scale. The scale is a single-item measure ranging from 0 (no exertion) to 10 (max exertion).
28 days
Secondary Outcomes (2)
Perceived Fatigue
28 days
Perceived Energy
28 days
Study Arms (2)
NutraStem Active
EXPERIMENTALDaily supplementation with NutraStem Active; 2 capsules per day for 28 days
Placebo
PLACEBO COMPARATORDaily supplementation with placebo; 2 capsules per day for 28 days
Interventions
Eligibility Criteria
You may qualify if:
- healthy
- physically active
- non-smoker
You may not qualify if:
- known cardiovascular, pulmonary, or metabolic disease
- body mass index greater than 35
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Health and Exercise Science Laboratory
Tampa, Florida, 33620, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Marcus Kilpatrick
- Organization
- University of South Florida
Study Officials
- PRINCIPAL INVESTIGATOR
Marcus W Kilpatrick, PhD
University of South Florida
- STUDY DIRECTOR
Danielle Williams
University of South Florida
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 11, 2014
First Posted
May 9, 2014
Study Start
May 1, 2014
Primary Completion
May 1, 2015
Study Completion
May 1, 2015
Last Updated
December 7, 2020
Results First Posted
December 7, 2020
Record last verified: 2015-12